CORONA REMEDIES
|
Last 5 Year ShareHolding (%) History of CORONA REMEDIES
Last 8 Quarters| Mar2026 | Dec2025 | ||
|---|---|---|---|
| Promoter and Promoter Group | |||
| Indian Promoters | 69.00 % | 69.00 % | |
| Individuals / Hindu Undivided Family | 69.00 % | 69.00 % | |
| Central Government/State Government(s) | - | - | |
| Bodies Corporate | - | - | |
| Financial Institutions / Banks | - | - | |
| Partnership Firms | - | - | |
| Promoter Group | - | - | |
| Employees Welfare Fund | - | - | |
| Other | - | - | |
| Any Others (Specify) | - | - | |
| Foreign Promoters | - | - | |
| Non-Residents Individuals / Foreign Individuals | - | - | |
| 'Bodies Corporate | - | - | |
| Institutions | - | - | |
| Other | - | - | |
| Any Others (Specify) | - | - | |
| Total of Promoter and Promoter Group | 69.00 % | 69.00 % | |
| Pledged Promoter Holdings | 0 % | 0 % | |
| Public Shareholding | |||
| Institutions | 9.27 % | 8.60 % | |
| Mutual Funds / UTI | 6.35 % | 6.38 % | |
| Financial Institutions / Banks | - | - | |
| Insurance Companies | 0.58 % | 0.34 % | |
| Foreign Institutional Investors | - | - | |
| Venture Capital Funds | - | - | |
| Foreign Venture Capital Investors | - | - | |
| Alternate Investment Funds | 0.09 % | 0.05 % | |
| Foreign Portfolio investors | 2.25 % | 1.84 % | |
| Provident funds / Pension funds | - | - | |
| Multilateral & Bileteral Development Financial Institution | - | - | |
| Any Others (Specify) | - | - | |
| Central Government / State Government(s) | - | - | |
| Foreign Financial Institutions / Banks | - | - | |
| Stressed Assets Stabilisation Fund | - | - | |
| Foreign Financial Institutions | - | - | |
| State Finance Corporation | - | - | |
| Foreign Bodies DR | - | - | |
| Other | - | - | |
| Non-Institutions | 21.74 % | 22.40 % | |
| Bodies Corporate | 0.77 % | 0.79 % | |
| Individuals | - | - | |
| Individual shareholders holding nominal share capital up to Rs. 1 lakh | 0.69 % | 1.14 % | |
| Individual shareholders holding nominal share capital in excess of Rs. 1 lakh | 0.08 % | 0.22 % | |
| NBFCs Registed with RBI | - | - | |
| Employee Trusts | - | - | |
| Any Others (Specify) | 0.44 % | - | |
| Clearing Members | - | 0.02 % | |
| Non Resident Indians | 0.01 % | 0.01 % | |
| Directors & their Relatives & Friends | - | - | |
| Foreign Collaborators | - | - | |
| Foreign Mutual Fund | - | - | |
| Trusts | 0.41 % | 0.41 % | |
| Hindu Undivided Families | 0.03 % | 0.05 % | |
| Foreign Corporate Bodies | 19.76 % | 19.76 % | |
| Shares in transit | - | - | |
| Market Maker | - | - | |
| ESOP/ESOS/ESPS | - | - | |
| Societies | - | - | |
| Escrow Account | - | - | |
| Any Other | - | - | |
| Total Public Shareholding | 31.00 % | 31.00 % | |
| - | - | ||
| Total of Promoter and Public Shareholding | 100.00 % | 100.00 % | |
Compare ShareHolding of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,464.0 Cr | 1.7% | 17.7% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 1.7% |
17.7% |
|
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses
